The norepinephrine transporter (NET) terminates noradrenergic signals by clearing released NE from extracellular synapses. Stimulation of presynaptic receptors linked to pathways involving second messengers, kinases and phosphatases regulate the activity of NET by modulating surface trafficking and catalytic activity. Further clarification of these pathways may suggest candidates for novel therapeutics as well as identify mechanisms that may be altered in disease states. NET interacts with proteins such as syntaxin 1A, protein phosphatase 2A, PICK 1 and Hic-5. The interactions are known to influence NET activity and trafficking, and participate in cellular responses to NET-targeted medications/ psychostimulants. To better understand these regulatory mechanisms, I propose a proteomic analysis to elucidate a more complete picture of NET protein complexes. In this effort, NET will be immunoprecipitated from stably transfected neuroblastoma cell lines and the proteins that co-immunoprecipitate with NET will be analyzed by mass spectrometry (MS) using LC-MS/MS (liquid chromatography coupled tandem mass spectrometry) method. Identified proteins will be validated for the interactions with NET and further studied for influences on co-localization, trafficking and activity of NET. These approaches will identify novel interacting proteins that can elucidate regulatory pathways controlling NE clearance capacity and provide information on new targets for pharmacological manipulation in neurological and psychiatric disorders. The relevance to public health: The norepinephrine transporter (NET) is a target of antidepressants. I propose a proteomic analysis to better understand regulatory mechanisms of NET. This approach will identify novel interacting proteins that can elucidate regulatory pathways controlling NE clearance capacity and provide information on new targets for pharmacological manipulation in neurological and psychiatric disorders. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Exploratory/Developmental Grants (R21)
Project #
7R21MH073662-03
Application #
7563171
Study Section
Neurotransporters, Receptors, and Calcium Signaling Study Section (NTRC)
Program Officer
Asanuma, Chiiko
Project Start
2006-01-01
Project End
2008-12-31
Budget Start
2008-01-01
Budget End
2008-12-31
Support Year
3
Fiscal Year
2007
Total Cost
$73,895
Indirect Cost
Name
Yale University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Sung, Uhna; Binda, Francesca; Savchenko, Valentina et al. (2017) Ca2+ dependent surface trafficking of norepinephrine transporters depends on threonine 30 and Ca2+ calmodulin kinases. J Chem Neuroanat 83-84:19-35
Sung, Uhna; Blakely, Randy D (2007) Calcium-dependent interactions of the human norepinephrine transporter with syntaxin 1A. Mol Cell Neurosci 34:251-60